Company intelligence / Profile preview

ChiRhoClin, Inc.

Burtonsville, Maryland, United Stateschirhoclin.com ↗

Ownership: Private
Development stage: Commercial

Overview

ChiRhoClin specializes in orphan drug development for gastrointestinal and radiological applications. Its lead product, ChiRhoStim® (Human Secretin for Injection), has FDA approval for pancreatic function testing, facilitating cannulation during ERCP procedures, gastrinoma testing, and supporting imaging diagnostics. The company collaborates with hospitals and universities to advance pancreatic disease research. Clinical results have established the utility of ChiRhoStim® in improving diagnostic accuracy and procedural success rates in relevant indications.

Therapeutic areas: GastroenterologyOncology
Modalities: Synthetic peptides (notably secretin)
Industry: Biotech

Drug pipeline

3 assets

secretin

Approved

2 more assets in the full pipeline.

Partnerships

PCI Pharma Services – manufacturing/packaging partnership to ensure supply continuity of ChiRhoStim®

Beyond the preview

Go deeper on ChiRhoClin, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChiRhoClin, Inc..